MS8815 is a selective PROTAC degrader targeting enhancer of zeste homolog 2 (EZH2). Its design enables effective inhibition of EZH2, making it a valuable tool for investigating its role in biological processes, particularly in the context of triple-negative breast cancer research.
Usually ships within 24 hours.